Genomtec Overview

  • Founded
  • 2016
  • Status
  • Public
  • Employees
  • 22
  • Stock Symbol
  • GMT
Stock Symbol
  • Share Price
  • $3.41
  • (As of Friday Closing)

Genomtec General Information


Genomtec SA is an innovative technology company which works in the area of molecular diagnostics. It is a manufacturer of mobile molecular analyzers. The device are designed to identify pathogens including viruses, bacteria, and fungi by amplifying and detecting specific DNA and RNA fragments.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Medical Records Systems
Stock Exchange
Primary Office
  • Ul. Stabłowicka 147
  • PORT Budynek 2
  • Wrocław, 54-066
  • Poland

Genomtec Timeline

Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Genomtec Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.41 $3.50 $3.17 - $6.14 $27.9M 8.16M 126K -$0.06

Genomtec Financials Summary

In Thousands,
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
Revenue 5 5 40 3
EBITDA (425) (425) (394) (193)
Net Income (466) (466) (422) (206)
Total Assets 2,224 2,224 578 126
Total Debt 67 67 158
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Genomtec Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Genomtec‘s full profile, request access.

Request a free trial

Genomtec Executive Team (10)

Name Title Board Seat Contact Info
Boleslaw Winiarski Ph.D Chief Operating Officer
Jason Reece Chief Technology Officer
Małgorzata Małodobra-Mazur Co-Founder & Genetics and Diagnostic Processes Specialist
Jarek Oleszczuk Chief Business Officer
Henryk Roguszczak Head of the Design Processes Department & Co-Founder
You’re viewing 5 of 10 executive team members. Get the full list »

Genomtec Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genomtec Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Genomtec‘s full profile, request access.

Request a free trial